As of 4:02pm ET
| +1.21 / +1.65%|
The 30 analysts offering 12-month price forecasts for Novartis have a median target of 80.30, with a high estimate of 94.54 and a low estimate of 64.60. The median estimate represents a +7.63% increase from the last price of 74.61.
The current consensus among 33 polled investment analysts is to Hold stock in Novartis. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.